Senior insider sale
SVP, Research at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$839.3K
10.60K shares
What this filing means
SWAYZE ERIC plans to sell 10.60K shares of IONIS PHARMACEUTICALS INC valued at approximately $839.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001972481-26-000211
Officer· SVP, Research
Since Jan 2020
10.60K
Shares to sell
$839.3K
Approx. market value
10.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Restricted Stock
Equity Compensation
2/1/2024
1.77KRestricted Stock
Equity Compensation
2/23/2023
1.90KRestricted Stock
Equity Compensation
1/15/2023
1.96KRestricted Stock
Equity Compensation
1/15/2022
3.11KRestricted Stock
Equity Compensation
1/15/2021
1.86KTotal acquired10.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2024 | Restricted Stock Equity Compensation | 1.77K | — |
2/23/2023 | Restricted Stock Equity Compensation | 1.90K | — |
1/15/2023 | Restricted Stock Equity Compensation | 1.96K | — |
1/15/2022 | Restricted Stock Equity Compensation | 3.11K | — |
1/15/2021 | Restricted Stock Equity Compensation | 1.86K | — |
| Total | 10.60K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
10.60K
Market value
$839.3K
6/25/2026
Total
Units
10.60K
Value
$839.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2026 | 10.60K | $839.3K | Nasdaq | Planned |
| Total | 10.60K | $839.3K | ||